<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04506580</url>
  </required_header>
  <id_info>
    <org_study_id>Dermabond vs. Subcuticular</org_study_id>
    <nct_id>NCT04506580</nct_id>
  </id_info>
  <brief_title>Comparison of Postoperative Wound Between Dermabond Prineo(2-octyl Cyanoacrylate Adhesive and Polyester Mesh) and Subcuticular Suture in Simultaneous Total Knee Arthroplasty</brief_title>
  <official_title>Comparison of Postoperative Wound Between Dermabond PRINEO™(2-octyl Cyanoacrylate Adhesive and Polyester Mesh) and Subcuticular Suture in Simultaneous Total Knee Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Catholic University of Korea</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Catholic University of Korea</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to compare the clinical results of postoperative wound between Dermabond&#xD;
      PRINEO™(2-octyl Cyanoacrylate adhesive and polyester mesh) and subcuticular suture in&#xD;
      simultaneous total knee arthroplasty&#xD;
&#xD;
      There is previous studies over whether or not to use skin adhesive material is superior or&#xD;
      inferior to subcuticular suture This study prospectively randomized patients receiving&#xD;
      bilateral total knee arthroplasty(TKA). Patients preference and clinical results was&#xD;
      investigated in both knee of same patients who received skin adhesive or subcuticular suture&#xD;
      in each knee.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">March 6, 2019</start_date>
  <completion_date type="Anticipated">July 30, 2020</completion_date>
  <primary_completion_date type="Actual">July 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
    <masking_description>Double blind</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>wound Hypertrophy scale at postoperative 6 month</measure>
    <time_frame>at postoperative 6 months</time_frame>
    <description>Vancouver scar scale, patient and observer report scar assessment scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Skin closure time</measure>
    <time_frame>operation day</time_frame>
    <description>Skin closure time for each group</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>wound complication</measure>
    <time_frame>postoperative 2 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>wound complication</measure>
    <time_frame>postoperative 6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>wound complication</measure>
    <time_frame>postoperative 3 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>wound complication</measure>
    <time_frame>postoperative 6 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stitch out time</measure>
    <time_frame>postoperative 2 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stitch out visual visual analogue scale(VAS)</measure>
    <time_frame>postoperative 2 weeks</time_frame>
    <description>VAS range from 1 to 10 ( 1means minimal pain 10 means maximal pain)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Osteoarthritis, Knee Cutaneous Suture, Dermabond, Subcuticular Suture</condition>
  <arm_group>
    <arm_group_label>Dermabond group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>close capsule using 1-0 vicryl suture material close subq layer using 1-0 and 2-0 bicryl suture material and close skin layer using DERMABOND™ PRINEO™</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Subcuticular group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>close capsule using 1-0 vicryl suture material close subq layer using 1-0 and 2-0 bicryl suture material and close skin layer using 3-0 Dermalon with subcuticular suture method</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>DERMABOND™ PRINEO™(2-octyl Cyanoacrylate Adhesive and Polyester Mesh) vs subcuticular nylon suture</intervention_name>
    <description>DERMABOND™ PRINEO™(2-octyl Cyanoacrylate Adhesive and Polyester Mesh) and subcuticular nylon suture are applied for each knee</description>
    <arm_group_label>Dermabond group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients for total knee arthroplasty&#xD;
&#xD;
          -  having medicare insurance&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Rheumatoid arthritis&#xD;
&#xD;
          -  Other inflammatory arthritis&#xD;
&#xD;
          -  Neuropsychiatric patients&#xD;
&#xD;
          -  Allergy or intolerance to study material&#xD;
&#xD;
          -  Patients with an American Society of Anesthesiologists(ASA) score of IV (angina,&#xD;
             congestive heart failure, dementia, cerebrovascular accident)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yong In, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>the Catholic Univerisity of Korea Seoul St Mary's hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Seoul St. Mary's Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>06591</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>February 1, 2020</study_first_submitted>
  <study_first_submitted_qc>August 6, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 10, 2020</study_first_posted>
  <last_update_submitted>August 6, 2020</last_update_submitted>
  <last_update_submitted_qc>August 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Catholic University of Korea</investigator_affiliation>
    <investigator_full_name>Yong In</investigator_full_name>
    <investigator_title>Head of Orthopaedic Surgery</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

